SCHEMBL19230649

SCHEMBL19230649

COC(=O)c1ccc2c(c1)OCC(c1ccc(OC3CCCCO3)cc1Cl)O2

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.37
RAB9A P51151 5/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
SMN1; SMN2 Q16637 3/20 0.36
TSHR P16473 2/20 0.36
KDM4E B2RXH2 1/20 0.36
MAPT P10636 1/20 0.34
ALOX15 P16050 1/20 0.34
HSD17B10 Q99714 1/20 0.34
HSD11B1 P28845 1/20 0.34
HCRTR2 O43614 2/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
HCRTR1 O43613 1/20 0.34
CTSD P07339 1/20 0.34
BACE1 P56817 1/20 0.34
SLC6A2 P23975 1/20 0.33
SLC6A4 P31645 1/20 0.33
SLC6A3 Q01959 1/20 0.33
CASP3 P42574 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28649927 0.91 MEN1 (0.41) NPC1RAB9AMEN1KMT2AHSD11B1
SCHEMBL19230646 0.87 HSD11B1 (0.36) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL19230648 0.79 RAB9A (0.42) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL19230574 0.75 HSD11B1 (0.39) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL25621200 0.74 HPGD (0.47) NPC1RAB9ASMN1; SMN2L3MBTL1HPGD
SCHEMBL4020110 0.74 NPC1 (0.51) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL19230581 0.72 NR1H4 (0.58)
SCHEMBL19230732 0.70 NR1H4 (0.34) NPC1RAB9AMEN1KMT2A
SCHEMBL16073032 0.70 ACR (0.48) NPC1RAB9AMEN1KMT2AKDM4E
SCHEMBL14422348 0.69 ALDH1A1 (0.51) NPC1RAB9AMEN1KMT2AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108602811-B FXR receptor agonists 轩竹生物科技有限公司 2021-11-16 CN disclosed
WO-2017133521-A1 FXR RECEPTOR AGONIST 山东轩竹医药科技有限公司 2017-08-10 WO disclosed